BRCA2 and prostate carcinoma: Although this represents a substantially elevated RR of earlier-onset prostate cancer associated with carrying a germline protein-truncating BRCA2 mutation, such mutations are very rare (∼0.1%) in the general US population (Malone et al, 2006).